Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer

BACKGROUND: LRIG1, the founding member of the LRIG (leucine-rich repeat and immunoglobulin-like domain) family of transmembrane proteins, is a negative regulator of receptor tyrosine kinases and a tumour suppressor. Decreased LRIG1 expression is consistently observed in cancer, across diverse tumour...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeh-Garcia, Maxine, O’Geen, Henriette, Simion, Catalina, Gephart, Melanie Hayden, Segal, David J., Sweeney, Colleen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346006/
https://www.ncbi.nlm.nih.gov/pubmed/35440669
http://dx.doi.org/10.1038/s41416-022-01812-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346006/
https://www.ncbi.nlm.nih.gov/pubmed/35440669
http://dx.doi.org/10.1038/s41416-022-01812-8

Ejemplares similares